296 related articles for article (PubMed ID: 11071880)
1. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
3. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK
Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation.
Rangwala SM; O'Brien ML; Tortorella V; Longo A; Loiodice F; Noonan DJ; Feller DR
Chirality; 1997; 9(1):37-47. PubMed ID: 9094202
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
6. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
7. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice.
Cook WS; Jain S; Jia Y; Cao WQ; Yeldandi AV; Reddy JK; Rao MS
Exp Cell Res; 2001 Aug; 268(1):70-6. PubMed ID: 11461119
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator activated receptor-alpha expression in human liver.
Palmer CN; Hsu MH; Griffin KJ; Raucy JL; Johnson EF
Mol Pharmacol; 1998 Jan; 53(1):14-22. PubMed ID: 9443928
[TBL] [Abstract][Full Text] [Related]
10. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
Edvardsson U; Alexandersson M; Brockenhuus von Löwenhielm H; Nyström AC; Ljung B; Nilsson F; Dahllöf B
Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
[TBL] [Abstract][Full Text] [Related]
11. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
[TBL] [Abstract][Full Text] [Related]
14. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
[TBL] [Abstract][Full Text] [Related]
15. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats.
Rao MS; Papreddy K; Musunuri S; Okonkwo A
In Vivo; 2002; 16(2):145-52. PubMed ID: 12073774
[TBL] [Abstract][Full Text] [Related]
16. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
Sugden MC; Bulmer K; Gibbons GF; Holness MJ
Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
[TBL] [Abstract][Full Text] [Related]
17. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
18. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
